Software as a Medical Device (SaMD) is poised to change how patients and health care providers interact, and it’s streamlining the way data is shared, tracked and analyzed. This has huge implications for biopharma and medtech companies, whose success depends on matching the right patients with the right diagnostics and treatments—and making a compelling case for reimbursement with payers.
BrightInsight is the industry leader in bringing regulated SaMD solutions to market. Learn more about how BrightInsight’s compliant platform accelerates time to market for leading biopharma and medtech companies’ SaMD solutions.
Insights from top digital health executives on how to speed time to market and lower costs for SaMD solutions.
Read the White Paper
Roche developed a digital dosage calculator to aid prescribing physicians and maximize Hemlibra’s therapeutic benefits for patients with Hemophilia A. Rather than engineer their own infrastructure, applications and data stores, Roche partnered with BrightInsight and significantly accelerated time to market.
Read the Case Study
While the potential applications for SaMD are myriad, a recent survey found that disease management was the most promising use case.
This new guidance from the FDA has important information for anyone operating in the digital health space.
Learn More
Learn more about how Roche launched a CE-marked dosing calculator to treat Hemophilia A in just 6 months in this conversation with Paul Upham, Head of Smart Devices at Roche/Genentech.
Watch